Oral fluid roadside analysis

Phase I of the Oral Fluid Roadside Analysis Pilot Program provided valuable data on the overall performance and utility of the Roadside Oral Fluid Instrument. However, the data set for drug classes were not large enough to achieve a high confidence level in the obtained results. In December of 2018, the Michigan Legislature approved the expansion of the Oral Fluid Roadside Analysis Pilot Program. The purpose of Phase II was to collect and analyze additional data to better evaluate the roadside oral fluid test instrument. The expanded Oral Fluid Roadside Analysis Pilot Program will be referred to as Phase II throughout this report.
The expansion of the pilot, Phase II, began on October 1, 2019, and concluded on September 30, 2020. Phase II collected data from 693 incidents and 661 Roadside Oral Fluid Tests. There were 131 Drug Recognition Experts (DRE’s) from 65 different law enforcement agencies that participated
in Phase II. The expansion of the pilot included 69 counties in Michigan during Phase II.